We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
The Drug, Chemical & Associated Technologies Association (DCAT) Week took place in New York City the week of March 16, and again proved that this gathering is a terrific networking event for the pharmaceutical industry and its partners. Celebrating its 125th Anniversary, the association demonstrated its continued relevance and leadership in our business sector. DCAT Week always provides a unique opportunity for companies like West to engage in high-level, strategic meetings with our key customers and other business partners.
One of the hallmarks of DCAT Week is the Educational Programming. Attendees were given the opportunity to join a variety of sessions on topics pertaining to the state of our industry as well as its future. A highlight of the week (as always!) was the PharmaChem Outlook session, with a deep dive from IMS Health’s Vice President of Global Pharma Strategy, Graham Lewis, on the global pharmaceutical market and key trends.
Attendees were also able to hear from industry and regulatory experts on other topics such as the FDA’s Quality Metrics initiative and new approaches under the recently formed Office of Pharmaceutical Quality. Of particular interest to suppliers, such as West, was the session regarding “Value Creation through Strategic and Collaborative Sourcing,” which included insights and case studies from key pharmaceutical companies such as Roche, GSK, Lilly and Amgen regarding best practices to co-create value in the supply chain with key supplier partners.
In addition to DCAT Week, the Association has several events throughout the year. To learn more, visit www.dcat.org.
In the third and final installment of the <a href="https://www.youtube.com/watch?v=WrAvjl1C1iI"><span style="text-decoration: underline;">West On The Road</span></a> visit with our Clearwater, Florida facility, we dive a little bit deeper into the day-to-day processes and outside-the-box thinking that allows us to deliver packaging components and drug delivery systems of the highest quality.
Since the 2012 New England Compounding Center tragedy that linked a deadly fungal meningitis outbreak to a failure to use current good manufacturing practices (cGMP),<sup>1</sup> compounding pharmacies have faced increasing scrutiny and regulation by the U.S. Food and Drug Administration (FDA). While registering with the FDA is still voluntary, only compounding pharmacies that register, and pass inspection, will be granted “503B” status as compounding outsourcing facilities under Section 503B of the Federal Food, Drug, and Cosmetic Act.<sup>2</sup>
West is proud to announce that we have published our 2021 Corporate Responsibility (CR) Report, Purpose. Driven., which is now available on <a href="/about-west/corporate-responsibility">West’s website.</a> <br />This is West’s 6<sup>th</sup> annual CR Report, and highlights ESG successes from over the past year, including progress on environmental sustainability goals, diversity and inclusion, and success around the Company’s philanthropic efforts. The publication also highlights some of the recognition received for our ESG (Environmental, Social, Governance) performance, including placement in Barron’s Top 100 Most Sustainable Companies, Corporate Social Responsibility Programme of the Year from Pharma Industry Awards in Ireland, and a Silver Stevie Award for Corporate Social Responsibility.
The pharmaceutical industry is shifting toward pre-filled syringes (PFS) as the optimal delivery system for many drug products. The utility of a syringe system is dependent upon its ability to maintain good container closure integrity (CCI) through drug product shelf life.<br />
This week, West is delighted to be at the Parenteral Drug Association (PDA) Europe Annual Meeting in Berlin, Germany. During the show, we will provide more information on our <a href="/products/prefillable-systems/syringe-components/rigid-needle-shields-and-tip-caps">Rigid Needle Shield </a>(RNS). Designed to provide added safety for prefilled syringes with a staked needle, the West RNS helps assure the integrity of injectable drug products. The West RNS will be showcased along with West’s comprehensive product portfolio and technical insights.
English
Chinese
